Company Executive Chairman & CEO to Provide Corporate Updates on June 17th 2025Philadelphia, Pennsylvania--(Newsfile Corp. - June 12, 2025) -…
Mika's cancer app is a certified medical device clinically proven to help cancer patients cope with both the physical and…
Twenty promising early-career clinical investigators join a year-long mentorship and training program led by renowned international leaders, aimed at shaping…
Swiss biotech excellence returns to BIO 2025 in Boston, where Switzerland Global Enterprise presents 45 cutting-edge Swiss companies at the…
BRNO, Czech Republic, June 11, 2025 /PRNewswire/ -- In the heart of Europe, the Brno region is emerging as a…
BASKING RIDGE, N.J., June 11, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage…
Shares Expected to Begin Trading on a Split-Adjusted Basis on June 13, 2025SOLANA BEACH, Calif., June 11, 2025 (GLOBE NEWSWIRE)…
In Patients Receiving a Minimum of 55 mCi an Average 5.4 Months of PFS was Observed: Twice the Reported 2.25…
BRISBANE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company with a pipeline…
Facility provides additional funding for next steps of the Company’s growth, including the expected launch of bezuclastinib in 2026 On…